Doç. Dr. TUĞRUL PÜRNAK

Yayın Ağı

Makaleler 56

1. Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group

Gatselis N. K., Zachou K., Loza A. J. M., Cançado E. L. R., Arinaga-Hino T., Muratori P., et al.

European Journal of Internal Medicine , cilt.116, ss.43-50, 2023 (SCI-Expanded, Scopus)

2. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome

Efe C., Kulkarni A. V., Terziroli Beretta-Piccoli B., Magro B., Friedrich Staettermayer A., Cengiz M., et al.

HEPATOLOGY , cilt.76, sa.6, ss.1576-1586, 2022 (SCI-Expanded, Scopus)

3. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

Efe C., Lammert C., Tascilar K., Dhanasekaran R., Ebik B., Higuera-de la Tijera F., et al.

LIVER INTERNATIONAL , cilt.42, sa.3, ss.607-614, 2022 (SCI-Expanded, Scopus)

4. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

Efe C., Dhanasekaran R., Lammert C., Ebik B., Higuera-de la Tijera F., Aloman C., et al.

HEPATOLOGY , cilt.73, sa.6, ss.2099-2109, 2021 (SCI-Expanded, Scopus)

5. Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome

Efe C., Torgutalp M., Henriksson I., Alalkim F., Lytvyak E., Trivedi H., et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.36, sa.4, ss.936-942, 2021 (SCI-Expanded, Scopus)

6. Fasciola As An Unusual Cause of Cholangitis

Efe C., Umay A., PÜRNAK T.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.19, sa.4, 2021 (SCI-Expanded, Scopus)

7. Retrospective Evaluation of Hepatitis C Awareness in Turkey Through Two Decades

BALABAN H. Y., DAĞ O., Alp A., Tseveldorj N., Vahabov C., GÖKTAŞ M. A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.1, ss.88-96, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

8. High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation

Pape S., Gevers T. J. G., Vrolijk J. M., van Hoek B., Bouma G., van Nieuwkerk C. M. J., et al.

LIVER INTERNATIONAL , cilt.40, sa.9, ss.2164-2171, 2020 (SCI-Expanded, Scopus)

9. What Is the Optimal Dose of Predniso(lo)ne for Induction of Remission in Patients With Autoimmune Hepatitis?

Efe C., Ozaslan E., PÜRNAK T.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.18, sa.8, ss.1896-1897, 2020 (SCI-Expanded, Scopus)

10. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months

Pape S., Gevers T. J. G., Vrolijk J. M., van Hoek B., Bouma G., van Nieuwkerk C. M. J., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.18, sa.7, ss.1609-1621, 2020 (SCI-Expanded, Scopus)

11. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis

Efe C., Tascilar K., Henriksson I., Lytvyak E., Alalkim F., Trivedi H., et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.114, sa.7, ss.1101-1108, 2019 (SCI-Expanded, Scopus)

12. An unusual cause of gastrointestinal bleeding in an elderly patient

KÖKLÜ H., Dincer A., KUMBASAR U., DOĞRUL A. B., PÜRNAK T.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.5, ss.610-612, 2018 (SCI-Expanded, Scopus, TRDizin)

13. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis

Efe C., Al Taii H., Ytting H., Aehling N., Bhanji R. A., Hagstrom H., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.63, sa.5, ss.1348-1354, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Therapy-Related Severe Anemia

KÖKLÜ H., PÜRNAK T., Tseveldorj N., ALTAN E., ŞİMŞEK H.

ANNALS OF PHARMACOTHERAPY , cilt.52, sa.4, ss.397-398, 2018 (SCI-Expanded, Scopus)

15. Ulcerated colonic mass mimicking malignancy in an elderly patient

KÖKLÜ H., Imamoglu E., Tseveldorj N., SÖKMENSÜER C., PÜRNAK T., KAV T.

GERIATRICS & GERONTOLOGY INTERNATIONAL , cilt.18, sa.4, ss.651-653, 2018 (SCI-Expanded, SSCI, Scopus)

16. Second-line immunosuppressants for autoimmune hepatitis

Efe C., Ozaslan E., PÜRNAK T.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.30, sa.4, ss.490-491, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Methotrexate in the Treatment of Autoimmune Hepatitis

Efe C., Ozaslan E., PÜRNAK T.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.16, sa.1, ss.149, 2018 (SCI-Expanded, Scopus)

18. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis

Efe C., Hagstrom H., Ytting H., Bhanji R. A., Muller N. F., Wang Q., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.15, sa.12, ss.1950-1957, 2017 (SCI-Expanded, Scopus)

19. Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis

PÜRNAK T., Efe C., KAV T., Wahlin S., Ozaslan E.

DIGESTIVE DISEASES AND SCIENCES , cilt.62, sa.10, ss.2900-2907, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. AN UNUSUAL CAUSE OF ANEMIA IN AN ELDER: ISOLATED SPLENIC HEMANGIOMATOSIS AND HEMORRHAGIC TELANGIECTASIA

ÖZTÜRK Ö., KÖKLÜ S., BAŞAR Ö., PÜRNAK T., YÜKSEL O.

GASTROENTEROLOGY NURSING , cilt.39, sa.4, ss.317-318, 2016 (SCI-Expanded, SSCI, Scopus)

21. Inflammation and chemerin in colorectal cancer

Erdogan S., YILMAZ F. M., Yazici O., Yozgat A., Sezer S., Ozdemir N., et al.

TUMOR BIOLOGY , cilt.37, sa.5, ss.6337-6342, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. CROHN DISEASE PRESENTED WITH A GIANT COLONIC MASS

ÖZTÜRK Ö., KÖKLÜ S., BAŞAR Ö., PÜRNAK T., YÜKSEL O.

GASTROENTEROLOGY NURSING , cilt.39, sa.3, ss.235-237, 2016 (SCI-Expanded, SSCI, Scopus)

23. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis

Efe C., Cengiz M., Kahramanoglu-Aksoy E., YILMAZ B., Ozseker B., Beyazit Y., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.27, sa.6, ss.649-654, 2015 (SCI-Expanded, Scopus)

24. Overview of Venous Thrombosis in Inflammatory Bowel Disease

PÜRNAK T., YÜKSEL O.

INFLAMMATORY BOWEL DISEASES , cilt.21, sa.5, ss.1195-1203, 2015 (SCI-Expanded, Scopus)

25. An Unusual Presentation of Malignant Melanoma: Amelanotic Gastric Metastasis

ÖZTÜRK Ö., BAŞAR Ö., KÖKLÜ S., YÜKSEL O., PÜRNAK T., SÖKMENSÜER C.

AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.110, sa.3, ss.476-477, 2015 (SCI-Expanded, Scopus)

26. Nitric oxide is a potential mediator of hepatic inflammation and fibrogenesis in autoimmune hepatitis

Beyazit Y., Efe C., Tanoglu A., Purnak T., Sayilir A., Taskiran I., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.50, sa.2, ss.204-210, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Low Serum Vitamin D Levels Are Associated with Severe Histological Features and Poor Response to Therapy in Patients with Autoimmune Hepatitis

EFE C., KAV T., AYDIN C., Cengiz M., IMGA N. N., Purnak T., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.59, sa.12, ss.3035-3042, 2014 (SCI-Expanded, Scopus)

28. The Comparison of Two Different 5.5 Fr Sphincterotomes for Selective Cannulation of the Common Bile Duct: A Prospective, Randomized Study

Ozaslan E., Purnak T., Efe C., Ozaslan N. G., Cengiz M.

DIGESTIVE DISEASES AND SCIENCES , cilt.59, sa.12, ss.3078-3084, 2014 (SCI-Expanded, Scopus)

29. Pregnancy in women with primary biliary cirrhosis

Efe C., Kahramanoglu-Aksoy E., YILMAZ B., Ozseker B., Takci S., Roach E. C., et al.

AUTOIMMUNITY REVIEWS , cilt.13, sa.9, ss.931-935, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Vitamin D Levels in Patients With Chronic Hepatitis B

Efe C., PÜRNAK T., Ozaslan E.

HEPATOLOGY , cilt.60, sa.2, ss.768, 2014 (SCI-Expanded, Scopus)

31. Factors Associated With Response to Therapy and Outcome of Patients With Primary Biliary Cirrhosis With Features of Autoimmune Hepatitis

Ozaslan E., Efe C., Heurgue-Berlot A., KAV T., Masi C., Purnak T., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.12, sa.5, ss.863-869, 2014 (SCI-Expanded, Scopus)

32. Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis

Efe C., Ozaslan E., Heurgue-Berlot A., KAV T., Masi C., Purnak T., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.26, sa.5, ss.532-537, 2014 (SCI-Expanded, Scopus)

33. Liver and Atherosclerosis

PÜRNAK T., Efe C., BAŞAR Ö.

GASTROENTEROLOGY , cilt.146, sa.5, ss.1427, 2014 (SCI-Expanded, Scopus)

34. Late autoimmune hepatitis after hepatitis C therapy

Efe C., Heurgue-Berlot A., Ozaslan E., Purnak T., Thiefin G., ŞİMŞEK H., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.25, sa.11, ss.1308-1311, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Authors' reply: 'Mean platelet volume could be a promising biomarker to monitor dietary compliance in celiac disease'

Purnak T., Beyazit Y., Efe C., Ozaslan E., Yuksel O., Altiparmak E.

UPSALA JOURNAL OF MEDICAL SCIENCES , cilt.118, sa.3, ss.208, 2013 (SCI-Expanded, Scopus)

36. Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C

Efe C., Wahlin S., Ozaslan E., Purnak T., Muratori L., Quarneti C., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.48, sa.4, ss.504-508, 2013 (SCI-Expanded, Scopus)

37. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis

Purnak T., Olmez S., Torun S., Efe C., Sayilir A., Ozaslan E., et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , cilt.37, sa.1, ss.41-46, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus-Related Cirrhosis

Koklu S., Tuna Y., Gulsen M. T., Demir M., Koksal A. S., KOÇKAR M. C., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.11, sa.1, ss.88-94, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Reply to Dr Onal: the importance of serum angiotensin-converting enzyme level in chronic hepatitis B

Purnak T., Beyazit Y., Efe C., Ozaslan E.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.13, sa.4, ss.504, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. The involvement of nitric oxide in the physiopathology of hepatoportal sclerosis

Purnak T., Beyazit Y., Ibis M., Koklu S., Efe C., Ozaslan E., et al.

CLINICAL BIOCHEMISTRY , cilt.45, ss.1450-1454, 2012 (SCI-Expanded, Scopus)

41. Mean platelet volume as a non-invasive marker of fibrosis in chronic hepatitis C

Purnak T., Beyazit Y., Efe C., Ozaslan E.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , cilt.36, sa.4, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B

Purnak T., Beyazit Y., Oztas E., Yesil Y., Efe C., Torun S., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.13, sa.2, ss.244-249, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Chronic hepatitis C, inflammatory bowel disease and interferon therapy

Efe C., Roach E. C., Purnak T., Ozaslan E.

JOURNAL OF CROHNS & COLITIS , cilt.6, sa.5, ss.626-627, 2012 (SCI-Expanded, Scopus)

44. Liver biopsy is a superior diagnostic method in some patients showing the typical laboratory features of autoimmune hepatitis

Efe C., Ozaslan E., Purnak T., Ozseker B., KAV T., BAYRAKTAR Y.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , cilt.36, sa.2, ss.185-188, 2012 (SCI-Expanded, Scopus)

45. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome

Efe C., Ozaslan E., KAV T., Purnak T., Shorbagi A., ÖZKAYAR Ö., et al.

AUTOIMMUNITY REVIEWS , cilt.11, sa.5, ss.330-334, 2012 (SCI-Expanded, Scopus)

46. Cerebral abscesses-a stroke mimic

Purnak T., Ozaslan E., Efe C.

AGE AND AGEING , cilt.40, sa.5, ss.645-646, 2011 (SCI-Expanded, Scopus)

47. Recent Insights Into the Relationship Between Inflammatory Liver Diseases and Atherosclerosis

Purnak T., Efe C., Beyazit Y., Ozaslan E., Astan R., Milanlioglu A., et al.

JOURNAL OF INVESTIGATIVE MEDICINE , cilt.59, sa.6, ss.904-911, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Mean platelet volume could be a promising biomarker to monitor dietary compliance in celiac disease

Purnak T., Efe C., Yuksel O., Beyazit Y., Ozaslan E., Altiparmak E.

UPSALA JOURNAL OF MEDICAL SCIENCES , cilt.116, sa.3, ss.208-211, 2011 (SCI-Expanded, Scopus)

49. A Comparison of Jurkat Cell-Reactive Anti-T Lymphocyte Globulin and Fetal Anti-Thymocyte Globulin Preparations in the Treatment of Aplastic Anemia

Serefhanoglu S., Buyukasik Y., Purnak T., Goker H., Sayinalp N., Haznedaroglu I. C., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.20, sa.4, ss.341-344, 2011 (SCI-Expanded, Scopus)

50. A novel fungal pathogen under the spotlight - Acremonium spp. associated fungaemia in an immunocompetent host

PÜRNAK T., Beyazit Y., Sahin G. O., Shorbagi A., AKOVA M.

MYCOSES , cilt.54, sa.1, ss.78-80, 2011 (SCI-Expanded, Scopus)

51. Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma

Altundag K., Dede D. S., Purnak T.

JOURNAL OF CLINICAL PATHOLOGY , cilt.60, sa.8, ss.958, 2007 (SCI-Expanded, Scopus)

52. Hormone receptor status as a prognostic factor in breast cancer patients with hepatic metastases treated by liver resection

Purnak T., Altundag K.

ANNALS OF SURGERY , cilt.246, sa.2, ss.338, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Hormone receptor status as a prognostic factor affecting the outcome of brain metastases

Harputluoglu H., Purnak T., Altundag K.

SUPPORTIVE CARE IN CANCER , cilt.15, sa.3, ss.347, 2007 (SCI-Expanded, Scopus)

54. Concomitant use of antioxidants may decrease the efficacy of cisplatin in cancer patients

Purnak T., Cengiz M., Altundag K.

MEDICAL HYPOTHESES , cilt.68, sa.5, ss.1177, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Global warming may increase the incidence and geographic range of Crimean-Congo Hemorrhagic Fever

Purnak T., Selvi N. A., Altundag K.

MEDICAL HYPOTHESES , cilt.68, sa.4, ss.924-925, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. Alterations in the 'local umbilical cord blood renin-angiotensin system' during pre-eclampsia

Acar K., Beyazit Y., Sucak A., Haznedaroglu I. C., Aksu S., Tuncer S., et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA , cilt.86, sa.10, ss.1193-1199, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. Hepatitis C Awareness Survey: Retrospective Evaluation of HCV Tests between 2000-2017

Balaban Y. H., DAĞ O., Alp A., PÜRNAK T., GÖKTAŞ M. A., Tseveldor N., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri) Sürdürülebilir Kalkınma

2. KRONİK GRANÜLOMATOZ HASTALIK VE YAYGIN DEĞİŞKEN İMMÜN YETMEZLİK HASTASINDA İNFLAMATUAR BAĞIRSAK HASTALIĞI OLGUSU

EYÜPOĞLU N. D., ÇALIK BAŞARAN N., ÖZIŞIK L., ÖZ Ş. G., PÜRNAK T., ÖCAL S., et al.

19. İç Hastalıkları Kongresi, Türkiye, 11 - 15 Ekim 2017, (Özet Bildiri)

3. Tacrolimus or Mycophenylate mofetil as a second-line therapeutic options in patients with Autoimmune Hepatitis: An international multicentre observational study

Efe C., Hagstrom H., Bhanji R. A., Mueller N. F., Wang Q., PÜRNAK T., et al.

66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Paraneoplastik intestinal dismotilite ve gastroparezi ile prezente olan küçük hücreli akciğer kanseri olgusu

ŞENER Y. Z., ÖZIŞIK L., ÇALIK BAŞARAN N., PÜRNAK T., TÜRKER F. A.

16. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 15 - 19 Ekim 2014, ss.235-236 Sürdürülebilir Kalkınma

5. PARANEOPLASTİK İNTESTİNAL MOTİLİTE VE GASTROPAREZİ İLE PREZENTE OLAN KÜÇÜK HÜCRELİ AKCİĞER KANSERİ OLGUSU

ŞENER Y. Z., ÖZIŞIK L., ÇALIK BAŞARAN N., PÜRNAK T., TÜRKER F. A.

16. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 15 - 19 Ekim 2014, ss.235, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

494

H-İndeks (WoS)

Atıf (Scopus)

104

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim